Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

It has been edited for length and clarity. I was diagnosed with neurofibromatosis type 1 with plexiform neurofibromas (NF1-PN) as a toddler, so I don't remember a time before the symptoms. Growing up, ...

RAHWAY, N.J., November 22, 2024--Merck’s WELIREG Approved in China for the Treatment of Adult Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors RAHWAY, N.J ...

Pathway is now the first and only FDA-approved companion diagnostic for identifying HER2-positive biliary tract cancer patients eligible for treatment with Ziihera.

Results from the Phase III SURMOUNT-1 study show that tirzepatide, a dual GIP and GLP-1 receptor agonist, achieved substantial average weight loss of 22.9% in patients with pre-diabetes and obesity.